How do the three active ingredients in Triumeq inhibit HIV replication?

In Triumeq, dolutegravir binds HIV integrase’s active site and blocks DNA strand transfer, while abacavir and lamivudine are converted intracellularly to active triphosphates that competitively inhibit HIV reverse transcriptase, primarily acting through incorporation into viral DNA as monophosphates to terminate the chain.